Copyright
©The Author(s) 2022.
World J Diabetes. Apr 15, 2022; 13(4): 319-337
Published online Apr 15, 2022. doi: 10.4239/wjd.v13.i4.319
Published online Apr 15, 2022. doi: 10.4239/wjd.v13.i4.319
Figure 3 Tau protein regulation.
A: Insulin and Tau protein with no insulin increase hyperphosphorylate of Tau folding the protein; B: O-GlcNAcylation and Tau protein can regulate glucose amination to serine and threonine decrease the formation of Tau folding. Some pictures were taken from Qiagen Pathways. GSK3: Glycogen synthase kinase-3; IGF-1: Insulin-like growth factor 1; Pi3K: Phosphoinositide-3 kinase; Akt: Serine/threonine specific protein kinase; GlcNAc: O-GlcNAcylation.
- Citation: Ortiz GG, Huerta M, González-Usigli HA, Torres-Sánchez ED, Delgado-Lara DL, Pacheco-Moisés FP, Mireles-Ramírez MA, Torres-Mendoza BM, Moreno-Cih RI, Velázquez-Brizuela IE. Cognitive disorder and dementia in type 2 diabetes mellitus. World J Diabetes 2022; 13(4): 319-337
- URL: https://www.wjgnet.com/1948-9358/full/v13/i4/319.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i4.319